United States (US) Metabolomics Market (2025-2031) | Size & Revenue, Industry, Value, Trends, Companies, Outlook, Segmentation, Forecast, Growth, Competitive Landscape, Analysis, Share

Market Forecast By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Personalized Medicine, Others), By Indication (Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Metabolic Disorders, Others), By End-user (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations) And Competitive Landscape
Product Code: ETC9970185 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Metabolomics Market Outlook
  • Market Size of United States (US) Metabolomics Market, 2024
  • Forecast of United States (US) Metabolomics Market, 2031
  • Historical Data and Forecast of United States (US) Metabolomics Revenues & Volume for the Period 2021- 2031
  • United States (US) Metabolomics Market Trend Evolution
  • United States (US) Metabolomics Market Drivers and Challenges
  • United States (US) Metabolomics Price Trends
  • United States (US) Metabolomics Porter's Five Forces
  • United States (US) Metabolomics Industry Life Cycle
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Biomarker Discovery for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Drug Discovery for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Toxicology Testing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Nutrigenomics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Personalized Medicine for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Oncological Disorders for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Cardiovascular Disorders for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Neurological Disorders for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Metabolic Disorders for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By End-user for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Academic and Research Institutes for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Pharmaceutical and Biotechnology Companies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Metabolomics Market Revenues & Volume By Contract Research Organizations for the Period 2021- 2031
  • United States (US) Metabolomics Import Export Trade Statistics
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By End-user
  • United States (US) Metabolomics Top Companies Market Share
  • United States (US) Metabolomics Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Metabolomics Company Profiles
  • United States (US) Metabolomics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Metabolomics Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Metabolomics Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Metabolomics Market - Industry Life Cycle

3.4 United States (US) Metabolomics Market - Porter's Five Forces

3.5 United States (US) Metabolomics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 United States (US) Metabolomics Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 United States (US) Metabolomics Market Revenues & Volume Share, By End-user, 2021 & 2031F

4 United States (US) Metabolomics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Metabolomics Market Trends

6 United States (US) Metabolomics Market, By Types

6.1 United States (US) Metabolomics Market, By Application

6.1.1 Overview and Analysis

6.1.2 United States (US) Metabolomics Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 United States (US) Metabolomics Market Revenues & Volume, By Biomarker Discovery, 2021- 2031F

6.1.4 United States (US) Metabolomics Market Revenues & Volume, By Drug Discovery, 2021- 2031F

6.1.5 United States (US) Metabolomics Market Revenues & Volume, By Toxicology Testing, 2021- 2031F

6.1.6 United States (US) Metabolomics Market Revenues & Volume, By Nutrigenomics, 2021- 2031F

6.1.7 United States (US) Metabolomics Market Revenues & Volume, By Personalized Medicine, 2021- 2031F

6.1.8 United States (US) Metabolomics Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Metabolomics Market, By Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Metabolomics Market Revenues & Volume, By Oncological Disorders, 2021- 2031F

6.2.3 United States (US) Metabolomics Market Revenues & Volume, By Cardiovascular Disorders, 2021- 2031F

6.2.4 United States (US) Metabolomics Market Revenues & Volume, By Neurological Disorders, 2021- 2031F

6.2.5 United States (US) Metabolomics Market Revenues & Volume, By Metabolic Disorders, 2021- 2031F

6.2.6 United States (US) Metabolomics Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Metabolomics Market, By End-user

6.3.1 Overview and Analysis

6.3.2 United States (US) Metabolomics Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F

6.3.3 United States (US) Metabolomics Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F

6.3.4 United States (US) Metabolomics Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F

7 United States (US) Metabolomics Market Import-Export Trade Statistics

7.1 United States (US) Metabolomics Market Export to Major Countries

7.2 United States (US) Metabolomics Market Imports from Major Countries

8 United States (US) Metabolomics Market Key Performance Indicators

9 United States (US) Metabolomics Market - Opportunity Assessment

9.1 United States (US) Metabolomics Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 United States (US) Metabolomics Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 United States (US) Metabolomics Market Opportunity Assessment, By End-user, 2021 & 2031F

10 United States (US) Metabolomics Market - Competitive Landscape

10.1 United States (US) Metabolomics Market Revenue Share, By Companies, 2024

10.2 United States (US) Metabolomics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All